Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the FDA revisits its decision to remove it.

The government has suggested weight-loss drugs could boost the economy by helping obese people in England get back to work. But NHS experts have warned treatment services are already overstretched ...

The stock of Eli Lilly and Company LLY has declined 1.7% already this week, losing almost $14 billion of its market value.

Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies say this will limit patient access.

Pharmacists can continue making compounded versions of generic tirzepatide, the active ingredient in popular medications ...

KELOWNA, BC / ACCESSWIRE / October 8, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX) & (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery technology, provides an update on ...

KELOWNA, BC / ACCESSWIRE / October 8, 2024 / (NASDAQ:LEXX) & (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator ...

IMS 2024 Isatuximab Quadruplet Approval Could Change MM Landscape IMTOZ trial findings and subsequent approval of Isa-VRd regimen for transplant-ineligible myeloma suggested the combo as a new ...

Like semaglutide—the drug behind Ozempic and Wegovy—tirzepatide is taken by injections and helps reduce appetite. So, did it work for Bunnie? "I woke up a pound and a half lighter," she noted ...

Thousands of patients came to rely on knockoff versions of drugs made with tirzepatide after shortages began as early as 2022. The US Food and Drug Administration allows ... Tirzepatide injections ...